Around 75 medication competitors dependent on synlet quality

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

To order this 485+ page report, which features 195+ figures and 200+ tables, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-/267.html

The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:

• Type of molecule
• Small Molecule
• Biologic

• Target disease indication

• Breast Cancer
• Colorectal Cancer
• Fallopian Tube Cancer
• Gastric Cancer
• Head and Neck Cancer
• Lung Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Others

• Type of synlet target

• APE1 / Ref-1
• Chk1
• GLS1
• PARP
• Pol θ
• PP2A
• Wee1

• Route of administration 
• Oral
• Intravenous

• Key geographical regions
• North America
• Europe
• Asia Pacific

• Rest of the World

The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the following companies, which we identified to be key players in this domain:

• AbbVie
• AstraZeneca
• AtlasMedx
• BeiGene
• Chordia Therapeutics
• Clovis Oncology
• GlaxoSmithKline
• IDEAYA Biosciences
• Mission Therapeutics
• Pfizer
• Repare Therapeutics
• Sierra Oncology

§  SyntheX Labs

Table of Contents

1. Preface

2. Executive Summary

3. Introduction to DNA Damage and Repair Systems
 

4. Introduction to Synthetic Lethality
 

5. Market Overview
 

6. Company Profiles
 

7. Emerging Trends on Social Media 
 

8. Publication Analysis
 

9. Abstract Analysis
 

10. Academic Grants Analysis
 

11. Funding and Investment Analysis
 

12. Target Benchmark Analysis

13. Role of Companion Diagnostics in Synthetic Lethality

14. Market Forecast
 

15. Concluding Remarks
 

16. Executive Insights

17. Appendix 1: Tabulated Data

18. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Article source: https://article-realm.com/article/Health-Fitness/Exercise/16935-Around-75-medication-competitors-dependent-on-synlet-quality.html